Kiniksa Pharmaceuticals
KNSA
KNSA
142 hedge funds and large institutions have $628M invested in Kiniksa Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 39 increasing their positions, 57 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.21% more ownership
Funds ownership: 98.97% → 101.18% (+2.2%)
4% more capital invested
Capital invested by funds: $606M → $628M (+$22.6M)
32% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 57
Holders
142
Holding in Top 10
3
Calls
$7.55M
Puts
$4.91M
Top Buyers
| 1 | +$29.8M | |
| 2 | +$7.17M | |
| 3 | +$5.74M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.77M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$3.78M | |
| 3 | -$3.51M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.18M |
| 5 |
Millennium Management
New York
|
-$3.11M |